The "AI in Clinical and Molecular Diagnostics Market" report has been added to ResearchAndMarkets.com's offering. The AI in Clinical and Molecular Diagnostics Market was valued at USD 2.6 billion in 2...
Autore: Business Wire
DUBLIN: The "AI in Clinical and Molecular Diagnostics Market" report has been added to ResearchAndMarkets.com's offering.
The AI in Clinical and Molecular Diagnostics Market was valued at USD 2.6 billion in 2024, and is expected to reach USD 8.9 billion by 2029, rising at a CAGR of 27.60%.
The market is driven by the rising demand for accurate and efficient diagnostic solutions. Advances in AI technologies such as machine learning and deep learning are enhancing the capabilities of traditional diagnostic methods in areas like imaging, genomics and laboratory testing. Factors promoting market expansion include a growing emphasis on personalized medicine, the need for earlier disease detection and the integration of AI into healthcare systems.
Major players in the market are investing in R&D, fostering strategic partnerships and expanding their product portfolios to leverage emerging opportunities. Countries in North America, Europe and Asia-Pacific are prioritizing digital health initiatives and innovative diagnostic solutions. The use of AI in clinical and molecular diagnostics will only grow, leading to breakthroughs that will improve patient outcomes and healthcare efficiency in the forecast period of 2024 to 2029.
Report Scope
This report on the global market for AI in clinical and molecular diagnostics entails a comprehensive analysis of the market size, growth trends and segmentation by technology and application. It examines drivers, challenges and opportunities influencing the adoption of AI technologies in clinical and molecular diagnostics, focusing on specific applications in imaging, genomics and laboratory diagnostics.
The report provides perspectives on the competitive environment, featuring profiles of leading companies and their strategic initiatives, as well as regional analyses that address the specific market dynamics in North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which in this report includes Latin America and the Middle East and Africa.
It also identifies emerging trends, such as the integration of AI in personalized medicine and telehealth. This report is an essential reference for stakeholders, including healthcare providers, technology developers and policymakers, seeking to navigate and capitalize on the evolving AI landscape in diagnostics.
The report includes:
AI in Clinical and Molecular Diagnostics Companies Featured in This Report:
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 112 |
| Forecast Period | 2024 - 2029 |
| Estimated Market Value (USD) in 2024 | $2.6 Billion |
| Forecasted Market Value (USD) by 2029 | $8.9 Billion |
| Compound Annual Growth Rate | 27.6% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Regulatory Structure
Chapter 5 Emerging Technologies and Developments
Chapter 6 Market Segmentation Analysis
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in AI in Clinical and Molecular Diagnostics: An ESG Perspective
Chapter 9 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/wco4d3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Fonte: Business Wire